Sunitinib Malate

FDA Approved: * January 30, 2014
Pharm Company: * MYLAN PHARMS INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sunitinib Malate Overview

Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.[1] Contents 1 Mechanism of action 2 Indications 2.1 Gastrointestinal...

Read more Sunitinib Malate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sunitinib

Recent Sunitinib Malate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sunitinib Malate
  • Capsule: 12.5mg, 25mg, 37.5mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sunitinib Malate or a similar ingredient: (1 result)

Related Sunitinib Malate Topics:

Brand names of Calcium Citrate Malate with their company names
Need Brand names of Calcium Citrate Malate with their company names ## It's called Rockbon. ## Calcium Citrate Malat... 2 replies
pizotifen malate
## Prescribed for Migraine headaches, in 1.5mg doses nightly... 1 reply






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA